» Articles » PMID: 29563048

Stem Cells: Their Source, Potency and Use in Regenerative Therapies with Focus on Adipose-derived Stem Cells - a Review

Overview
Journal Biotechnol Adv
Date 2018 Mar 23
PMID 29563048
Citations 237
Authors
Affiliations
Soon will be listed here.
Abstract

Stem cells can be defined as units of biological organization that are responsible for the development and the regeneration of organ and tissue systems. They are able to renew their populations and to differentiate into multiple cell lineages. Therefore, these cells have great potential in advanced tissue engineering and cell therapies. When seeded on synthetic or nature-derived scaffolds in vitro, stem cells can be differentiated towards the desired phenotype by an appropriate composition, by an appropriate architecture, and by appropriate physicochemical and mechanical properties of the scaffolds, particularly if the scaffold properties are combined with a suitable composition of cell culture media, and with suitable mechanical, electrical or magnetic stimulation. For cell therapy, stem cells can be injected directly into damaged tissues and organs in vivo. Since the regenerative effect of stem cells is based mainly on the autocrine production of growth factors, immunomodulators and other bioactive molecules stored in extracellular vesicles, these structures can be isolated and used instead of cells for a novel therapeutic approach called "stem cell-based cell-free therapy". There are four main sources of stem cells, i.e. embryonic tissues, fetal tissues, adult tissues and differentiated somatic cells after they have been genetically reprogrammed, which are referred to as induced pluripotent stem cells (iPSCs). Although adult stem cells have lower potency than the other three stem cell types, i.e. they are capable of differentiating into only a limited quantity of specific cell types, these cells are able to overcome the ethical and legal issues accompanying the application of embryonic and fetal stem cells and the mutational effects associated with iPSCs. Moreover, adult stem cells can be used in autogenous form. These cells are present in practically all tissues in the organism. However, adipose tissue seems to be the most advantageous tissue from which to isolate them, because of its abundancy, its subcutaneous location, and the need for less invasive techniques. Adipose tissue-derived stem cells (ASCs) are therefore considered highly promising in present-day regenerative medicine.

Citing Articles

Therapeutic Potential of Adipose-Derived Regenerative Cells for Ischemic Diseases.

Che Y, Shimizu Y, Murohara T Cells. 2025; 14(5).

PMID: 40072072 PMC: 11898683. DOI: 10.3390/cells14050343.


Advances in bioinspired polymer hydrogel systems with biomedical functionalities.

Ishihara K Sci Technol Adv Mater. 2025; 26(1):2469490.

PMID: 40065761 PMC: 11892067. DOI: 10.1080/14686996.2025.2469490.


Enhanced human adipose-derived stem cells with VEGFA and bFGF mRNA promote stable vascular regeneration and improve cardiac function following myocardial infarction.

Li K, Luo R, Yu X, Dong W, Hao G, Hu D Clin Transl Med. 2025; 15(3):e70250.

PMID: 40008489 PMC: 11862888. DOI: 10.1002/ctm2.70250.


aFGF gene-modified adipose-derived mesenchymal stem cells promote healing of full-thickness skin defects in diabetic rats.

Zhu Y, Chen P, Zhang Z, He X, Wang R, Fang Q Stem Cell Res Ther. 2025; 16(1):93.

PMID: 40001190 PMC: 11863861. DOI: 10.1186/s13287-025-04241-5.


Sustaining Brain Youth by Neural Stem Cells: Physiological and Therapeutic Perspectives.

Santos M, Moreira J, Santos S, Sola S Mol Neurobiol. 2025; .

PMID: 39985708 DOI: 10.1007/s12035-025-04774-z.